REGULATORY MECHANISMS OF UKRAINIAN PHARMACEUTICAL MARKET COMPETITIVENESS IN THE CONTEXT OF EUROPEAN INTEGRATION

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

  Iryna Budnikevych

  Vadym Honchar

Abstract

The purpose of the paper is to summarize and present the differences in the competitive environment of the European Union (EU) and Ukrainian pharmaceutical markets. The method of longitudinal study allowed to detect the patterns of changes and correlations for pharmaceutical products exports and imports volumes over twenty years (2001-2020). Methodology. The research is based on the definition of the pharmaceutical market as a complex socio-economic institution that fulfills the function of pricing medical products and utilizes them to ensure health care functioning. It indicates the population’s wellbeing and requires ongoing maintenance based on needs agreement of households, economic entities, and the state. The quantitative research is based on export-to-import coverage ratio calculations with the identification of pharmaceutical products fraction in the total volume of foreign trade, including the one with the EU. The results of the paper consist in the evaluation of the competitive environment of the European Union’s pharmaceutical market and statistical assessment of Ukrainian foreign trade of pharmaceutical products. They also include the definition of the European integration influence over the Ukrainian pharmaceutical market and well-reasoned recommendations about the application of the state and trade regulation mechanisms. In the paper, we defined the distinctive features of the European countries’ pharmaceutical markets and outlined their main characteristics that have connections to the transnational corporation’s activities, common market, and high concentration. Statistical data collected over 20 years indicated the dynamic development of the Ukrainian pharmaceutical market, despite its small-scale contribution to the foreign trade turnover. The dependence of Ukraine on the foreign supplies of drugs and medications is illustrated by the multiple excesses of imports over exports, especially in the trade relationships with the EU. The EU countries are the leading importers of pharmaceutical products to the Ukrainian market. However, the share of medical supplies exports from Ukraine to the EU countries is negligible. Their key exporters are post-Soviet and developing countries. The growth in Ukraine’s export potential is inextricably linked to the expansion of the competitiveness of domestic medical supplies. Practical implications consist in the development of recommendations concerning the GMP and GDP demands realization, domestic manufacturers cooperation with the leading foreign pharmaceutical companies, the penetration of transnational companies into the Ukrainian domestic pharmaceutical market based on imports of innovative technologies, the improvement of the marketing management of the pharmaceutical products exporting. The priority factor in the growth of the competitiveness of the Ukrainian pharmaceutical market is a successful combination of state and trade regulation mechanisms. The objects of these factors are the pricing policy for material resources and finished products, the introduction of innovations, tax exemptions, and export-import quotas implementation. They also include the establishment of traffic rates that depend on the market saturation with socially significant medical supplies, budget support of the prioritized subsectors of the pharmaceutical industry, and patent protection. The expected results concern the decrease in the dependence of the Ukrainian pharmaceutical market on the foreign distribution of the raw materials and finished products and strengthening the positions of the Ukrainian manufacturers in foreign markets. Value/originality. We evaluated the competitiveness of the national pharmaceutical market based on the criteria of foreign trade performance and detected the priorities of its growth, taking into consideration the synthesis of the state and trade regulation mechanisms.

How to Cite

Budnikevych, I., & Honchar, V. (2020). REGULATORY MECHANISMS OF UKRAINIAN PHARMACEUTICAL MARKET COMPETITIVENESS IN THE CONTEXT OF EUROPEAN INTEGRATION. Three Seas Economic Journal, 1(3), 1-8. https://doi.org/10.30525/2661-5150/2020-3-1
Article views: 43 | PDF Downloads: 43

##plugins.themes.bootstrap3.article.details##

Keywords

competitiveness, pharmaceutical market, national economy, European integration, market, state regulation

References

Bekarev, A. A., & Bekareva, S. V. (2014). Podkhod k otcenke konkurentosposobnosti natcionalnoi farmatcevticheskoi otrasli [An approach to assessing the competitiveness of the national pharmaceutical industry]. Novosibirsk State University Bulletin. Series: Socio-economic sciences, vol. 14(4), pp. 78–91.

Danzon, P. M. (1997). Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU. International Journal of the Economics of Business, vol. 4(3), pp. 301–322. doi: https://doi.org/10.1080/758523212

Derbenova, Ya. V. (2017). Potentsial pidvyshchennia konkurentospromozhnosti farmatsevtychnoi haluzi Ukrainy na natsionalnomu ta mizhnarodnomy rynkakh [Potential to increase the competitiveness of the pharmaceutical industry of Ukraine in the national and international markets]. Problems of innovation and investment development, vol. 10, pp. 3–7.

Dorovskyi, O. V. (2015). Metodychnyi pidkhid do otsinky konkurentospromozhnosti farmatsevtychnoi haluzi Ukrainy [Methodical approach to assessing the competitiveness of the pharmaceutical industry of Ukraine]. Financial space, vol. 2, pp. 358–368.

Duggan, M., Garthwaite, C. & Goyal, A. (2016). The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India. American Economic Review, vol. 106(1), pp. 99–135. doi: https://doi.org/10.1257/aer.20141301

Ekelund, М. & Persson, В. (2003). Pharmaceutical Pricing in a Regulated Market. Review of Economics and Statistics, vol. 85(2), pp. 298–306. doi: https://doi.org/10.1162/003465303765299828

Goldberg, P. K. (2010). Intellectual Property Rights Protection in Developing Countries: The Case of Pharmaceuticals. Journal of the European Economic Association, vol. 8 (2-3), pp. 326–353. doi: https://doi.org/10.1111/j.1542-4774.2010.tb00506.x

Iizuka, T. (2012). Physician Agency and Adoption of Generic Pharmaceuticals. American Economic Review, vol. 102 (6), pp. 2826–58. doi: https://doi.org/10.1257/aer.102.6.2826

Korolenko, N. V., & Holovatiuk, O. S. (2017). Lohistychne upravlinnia yak faktor pidvyshchennia mizhnarodnoi konkurentospromozhnosti ukrainskykh farmatsevtychnykh pidpryiemstv [Logistics management as a factor in increasing the international competitiveness of Ukrainian pharmaceutical companies]. Efficient economy, 1. Available at: http://nbuv.gov.ua/UJRN/efek_2017_1_20 (accessed 10 November 2020).

Kostiuk, H. V., & Kovalenko, A. V. (2013). Konkurentospromozhnist farmatsevtychnoi promyslovosti Ukrainy [Competitiveness of the pharmaceutical industry of Ukraine]. Efficient economy, vol. 11. Available at: http://nbuv.gov.ua/UJRN/efek_2013_11_94 (accessed 10 November 2020).

Kovalenko, I. (2014). Kryminalna vidpovidalnist za falsyfikatsiiu likarskykh zasobiv – vazhlyvyi krok adaptatsii farmatsevtychnoi haluzi do notm Yevropeiskoho Soiuzu [Criminal liability for falsification of medicines is an important step in the adaptation of the pharmaceutical industry to the norms of the European Union]. Legal Bulletin, vol. 1, pp. 262–266.

Lytvynenko, L. L., & Sobkova, A. O. (2015). Perspektyvy rozvytku farmatsevtychnoho rynku Ukrainy v umovakh pohlyblennia protsesiv yevrointehratsii [Prospects for the development of the pharmaceutical market of Ukraine in the conditions of deepening of European integration processes]. Problems of improving the efficiency of infrastructure, vol. 40, pp. 51–57.

Olefir, A. O. (2016). Obmezhennia sfery patentnoi okhorony yak zasib vidnovlennia konkurentospromozhnosti farmatsevtychnoi promyslovosti [Limiting the scope of patent protection as a means of restoring the competitiveness of the pharmaceutical industry]. Theory and practice of intellectual property, vol. 2, pp. 28–40.

Pasechnyk, O. V. (2014). Pravove zabezpechennia farmatsevtychnoi polityky Yevropeiskoho Soiuzu [Legal support of the pharmaceutical policy of the European Union]. Scientific Bulletin of the International Humanities University. Series: Jurisprudence, vol. 12(2), pp. 183–186.

State Statistics Service of Ukraine (2020). Commodity structure of Ukraine's foreign trade. Available at: http://www.ukrstat.gov.ua/ (accessed 10 November 2020).

Tronenko, N. (2014). Rol yevropeiskykh farmatsevtychnykh TNK u formuvanni spilnoho rynku YeS [The role of European pharmaceutical TNCs in the formation of the EU common market]. Ukrainian securities market, vol. 7, pp. 55–62.

Ustymenko, M. V. (2011). Formuvannia mizhnarodnykh kanaliv rospodilu na farmatsevtychnomu rynku Tsentralnoi i Skhidnoi Yevropy [Formation of international distribution channels in the pharmaceutical market of Central and Eastern Europe]. Marketing in Ukraine, vol. 2, pp. 22–25.